News & Insights

CJEU rules no authorisation of health claims made on glucose

von Dr. Manja Epping

Fujifilm declarations – High Court rules in favour of FKB in Humira challenge

von Dr Paul England

Rezeptortyrosinkinase II: Patent protection for a test method does not extend to test results

von Dr. Dietrich Kamlah

Calculation of SPC term in EU accession countries

Data exclusivity for innovators - a bridge too far?

von Andrew Payne

Pemetrexed in Germany: Federal Court of Justice sets aside decision of Appeal Court

von Christoph de Coster, LL.M. (UC Davis) und Julius Zacharias

CJEU confirms orphan drug market exclusivity

von Matthew Royle, Ph.D.

Intellectual Property in the Life Sciences, in review

von Dr Paul England

The implementation of the Nagoya Protocol in the EU

von Verena Bertram